2026 Annual Meeting | C182 - Child Neurology: Neuro-oncology
| 01:00 PM - 01:40 PM CDT | Speaker |
Pediatric CNS Tumors: Classification and Treatment
Sonia Partap, MD, FAAN |
| 01:40 PM - 02:20 PM CDT | Speaker |
Targeted Therapies for Low-Grade Glioma and Neurocutaneous Syndromes
Cynthia Campen, MD |
| 02:20 PM - 03:00 PM CDT | Speaker |
Beyond the Diagnosis: Navigating the Long-term Neurologic Toxicity in Survivors of Childhood Brain Tumors
Nicole Ullrich, MD, PhD, MMSci, FAAN |
| Nicole Ullrich, MD, PhD, MMSci, FAAN | The institution of Dr. Ullrich has received research support from Children's Tumor Foundation. Dr. Ullrich has received intellectual property interests from a discovery or technology relating to health care. Dr. Ullrich has received publishing royalties from a publication relating to health care. |
| Cynthia Campen, MD | Dr. Campen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Campen has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various Law Firms. The institution of Dr. Campen has received research support from Greathouse Family Foundation. |
| Sonia Partap, MD, FAAN | The institution of Dr. Partap has received research support from NIH. |